Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aluminum L Glutamate
2. Aluminum L-glutamate
3. D Glutamate
4. D-glutamate
5. Glutamate
6. Glutamate, Potassium
7. Glutamic Acid
8. Glutamic Acid, (d)-isomer
9. L Glutamate
10. L Glutamic Acid
11. L-glutamate
12. L-glutamate, Aluminum
13. L-glutamic Acid
14. Potassium Glutamate
1. 617-65-2
2. 2-aminopentanedioic Acid
3. Glutamic Acid, Dl-
4. Glutamic Acid Dl-form
5. Glutaminic Acid
6. H-dl-glu-oh
7. Dl-glu
8. Nsc 9967
9. Glutaminsaeure
10. H-dl-glu-oh.h2o
11. Glutamate
12. Poly(glutamic Acid)
13. Mfcd00063113
14. 2-aminoglutaric Acid
15. .alpha.-aminoglutaric Acid
16. Poly-l-glutamic Acid
17. 61ljo5i15s
18. 4-amino-1,5-pentanedioic Acid
19. Nsc-9967
20. Nsc620337
21. Nsc-206301
22. Poly-l-glutamic Acid (mw50,600)
23. L-2-aminoglutaric Acid
24. Dl-glutamicacid
25. 1-aminopropane-1,3-dicarboxylic Acid
26. (+-)-glutamic Acid
27. Acidum Glutaminicum
28. Glutamate, L-
29. Glutamic Acid-2,3,3,4,4-d5
30. Glutamic Acid (van)
31. .alpha.-glutamic Acid
32. Glutamic Acid (usan)
33. 49717-32-0
34. Glutamic Acid (h-3)
35. Glutamic Acid, (s)-
36. Glutaminic Acid (van)
37. Polyglutamic Acid
38. Nsc 206301
39. Glutamic Acid [usan:inn]
40. Einecs 210-522-2
41. Acide Glutamique [inn-french]
42. Acido Glutamico [inn-spanish]
43. Acidum Glutamicum [inn-latin]
44. Alpha-aminoglutaric Acid (van)
45. 2-aminopentanedioic Acid, (s)-
46. Brn 1723799
47. Glutaminsaure
48. Unii-61ljo5i15s
49. Polyglutamicacid
50. Mfcd00063112
51. Nsc-77686
52. Dl-glutamate
53. Poly(glutamicacid)
54. D,l-glutamic Acid
55. Dl-glutaminic Acid
56. Laevo-glutamic Acid
57. 2it
58. Poly(dl-glutamicacid)
59. (+/-)-glutamic Acid
60. Poly(dl-glutamic Acid)
61. Gamma-poly(glutamic Acid)
62. Glu146
63. 2-amino-pentanedioic Acid
64. Pentanedioic Acid, (s)-
65. 25513-46-6
66. Bmse000037
67. Bmse000913
68. Bmse001013
69. Wln: Qvyz2vq -l
70. Schembl2201
71. (.+/-.)-glutamic Acid
72. Nciopen2_000764
73. 4-04-00-03028 (beilstein Handbook Reference)
74. L-glutamic Acid-[2-13c]
75. Chembl276389
76. Dtxsid0046987
77. Chebi:18237
78. Chebi:53373
79. Nsc9967
80. Glutamic Acid, Dl- [ii]
81. 6899-05-4
82. Amy25304
83. Glutamic Acid Dl-form [mi]
84. Nsc77686
85. 2-aminopentanedioic Acidglutamic Acid
86. Ac7831
87. Bdbm50002371
88. Nsc143503
89. Nsc206301
90. Pdsp1_000621
91. Pdsp2_000618
92. Stk017280
93. Akos000118798
94. Akos016050534
95. Cs-w022635
96. Gamma-poly(glutamic Acid) Macromolecule
97. Hy-w041895
98. Nsc-620337
99. Ncgc00015470-02
100. Ac-24034
101. As-13496
102. Sy007089
103. Sy008517
104. Db-055206
105. Ft-0624571
106. Ft-0627824
107. Ft-0657301
108. Ft-0669004
109. Ft-0696960
110. G0058
111. C00302
112. D04341
113. Ab00443951-09
114. A854538
115. L001165
116. Q181136
117. Q-100712
118. Q27145702
119. Z57127545
120. 96c32356-219c-4821-af0e-30fcbfa1a321
| Molecular Weight | 147.13 g/mol |
|---|---|
| Molecular Formula | C5H9NO4 |
| XLogP3 | -3.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 147.05315777 g/mol |
| Monoisotopic Mass | 147.05315777 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 145 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A DL-Glutamic Acid API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DL-Glutamic Acid API, including repackagers and relabelers. The FDA regulates DL-Glutamic Acid API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DL-Glutamic Acid API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DL-Glutamic Acid API manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DL-Glutamic Acid API supplier is an individual or a company that provides DL-Glutamic Acid API active pharmaceutical ingredient (API) or DL-Glutamic Acid API finished formulations upon request. The DL-Glutamic Acid API suppliers may include DL-Glutamic Acid API API manufacturers, exporters, distributors and traders.
click here to find a list of DL-Glutamic Acid API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
DL-Glutamic Acid API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DL-Glutamic Acid API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DL-Glutamic Acid API GMP manufacturer or DL-Glutamic Acid API GMP API supplier for your needs.
A DL-Glutamic Acid API CoA (Certificate of Analysis) is a formal document that attests to DL-Glutamic Acid API's compliance with DL-Glutamic Acid API specifications and serves as a tool for batch-level quality control.
DL-Glutamic Acid API CoA mostly includes findings from lab analyses of a specific batch. For each DL-Glutamic Acid API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DL-Glutamic Acid API may be tested according to a variety of international standards, such as European Pharmacopoeia (DL-Glutamic Acid API EP), DL-Glutamic Acid API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DL-Glutamic Acid API USP).
LOOKING FOR A SUPPLIER?
